Skip to main content
. 2024 Jan 5;14:673. doi: 10.1038/s41598-023-51010-6

Table 1.

Baseline characteristics of 9891 chronic kidney diseases (CKD) patients in National Health and Nutrition Examination Survey (NHANES).

Characteristics Overall Alive Dead P value
n 9891 6193 3698
Age  < 0.001
 18–60 years 3498 (43.9) 3119 (57.6) 379 (15.6)
 ≥ 60 years 6393 (56.1) 3074 (42.4) 3319 (84.4)
Sex  < 0.001
 Female 5270 (57.6) 3520 (59.3) 1750 (54.0)
 Male 4621 (42.4) 2673 (40.7) 1948 (46.0)
Race  < 0.001
 Non-Hispanic White 4418 (66.7) 2221 (61.5) 2197 (77.4)
 Non-Hispanic Black 2258 (14.4) 1735 (15.4) 823 (12.3)
 Mexican American 1485 (7.3) 1073 (9.1) 412 (3.5)
 Other Hispanic 696 (5.2) 553 (6.3) 143 (2.9)
 Others 734 (6.5) 611 (7.7) 123 (3.9)
Education
 College or higher 3990 (48.2) 2758 (52.7) 1232 (39.0)
 High school 2360 (25.9) 1486 (25.7) 874 (26.5)
 Less than high school 3516 (25.7) 1940 (21.6) 1576 (34.1)
 Unknown 25 (0.2) 9 (0.1) 16 (0.3)
Marital status
 Married/cohabiting 5050 (54.6) 3332 (58.0) 1718 (47.8)
 Never married 1132 (11.4) 927 (14.1) 205 (5.8)
 Widowed/divorced/separated 3477 (31.9) 1763 (25.7) 1714 (44.7)
 Unknown 232 (2.1) 171 (2.3) 61 (1.7)
Smoking history
 Current 1667 (17.5) 1080 (18.0) 587 (16.5)
 Former 3174 (31.8) 1649 (27.5) 1525 (40.7)
 Never 4790 (49.0) 3213 (52.2) 1577 (42.5)
 Not available 260 (1.6) 251 (2.2) 9 (0.3)
Drinking history
 Heavy drinker 1712 (17.8) 1053 (17.4) 659 (18.6)
 Low-to-moderate drinker 4145 (47.2) 2865 (52.2) 1280 (36.9)
 Non-drinker 1609 (14.5) 953 (12.9) 656 (17.9)
 Not available 2425 (20.6) 1322 (17.6) 1103 (26.7)
Hypertension  < 0.001
 Yes 5956 (56.7) 3360 (50.5) 2596 (69.5)
 No 3898 (42.9) 2815 (49.3) 1083 (29.7)
 Unknown 25 (0.3) 10 (0.1) 15 (0.6)
 Missing 12 (0.1) 8 (0.1) 4 (0.1)
Diabetes  < 0.001
 Yes 2875 (25.1) 1622 (21.6) 1253 (32.1)
 No 6740 (72.1) 4407 (75.6) 2333 (65.0)
 Borderline 265 (2.7) 158 (2.7) 107 (2.8)
 Unknown 11 (0.1) 6 (0.1) 5 (0.1)
Cardiovascular diseases  < 0.001
 Yes (24.2) (15.8) (41.5)
 No (73.1) (80.9) (57.0)
 Unknown (2.7) (3.3) (1.5)
BMI, kg/m2  < 0.001
 Underweight 221 (2.4) 138 (2.4) 83 (2.4)
 Normal range 2090 (22.0) 1232 (21.5) 858 (23.2)
 Overweight 3260 (30.8) 1949 (30.3) 1257 (31.9)
 Obese 4041 (41.9) 2784 (44.6) 1257 (36.5)
 Not available 333 (2.8) 90 (1.3) 243 (6.1)
Serum uric acid, mg/dL 5.80 [4.70, 6.95] 5.70 [4.60, 6.80] 6.20 [5.10, 7.40]  < 0.001
CKD stage  < 0.001
 Stage 1 3219 (36.7) 2748 (46.6) 471 (16.4)
 Stage 2 2240 (21.6) 1302 (20.4) 938 (24.0)
 Stage 3a 2771 (27.6) 1455 (24.2) 1316 (34.4)
 Stage 3b 1138 (10.1) 493 (6.4) 645 (17.6)
 Stage 4 342 (2.7) 121 (1.5) 221 (5.2)
 Stage 5 181 (1.3) 74 (0.8) 107 (2.4)
eGFR, mL/min/1.73m2 72.88 [53.11, 100.95] 86.46 [57.06, 108.01] 56.75 [44.86, 78.92]  < 0.001
UACR, mg/g 45.37 [24.89, 101.82] 45.39 [30.26, 92.93] 45.17 [17.40, 121.42] 0.245
Creatinine, mg/dL 1.00 [0.77, 1.27] 0.92 [0.73, 1.19] 1.13 [0.90, 1.40]  < 0.001
Urinary albumin, μg/mL 42.50 [15.10, 114.60] 46.50 [16.20, 111.14] 36.98 [13.10, 119.00]
Albumin  < 0.001
 Normal (≥ 3.5 g/dL) 9536 (97.1) 6030 (98.0) 3506 (95.3)
 Low (< 3.5 g/dL) 355 (2.9) 163 (2.0) 192 (4.7)
AGR
 Normal (≥ 1) 9204 (95.0) 5858 (96.2) 3506 (92.3)
 Low (< 1) 677 (4.9) 325 (3.6) 352 (7.7)
 Not available 10 (0.1) 10 (0.2) 0 (0.0)
HbA1c, % 5.70 [5.30, 6.30] 5.60 [5.30, 6.20] 5.80 [5.40, 6.50]  < 0.001
Intakes during past 24 h
 Energy, kcal 1737.00 [1285.00, 2318.00] 1830.28 [1357.00, 2439.91] 1576.00 [1192.09, 2105.14]
 Carbohydrate, g 210.67 [154.15, 284.15] 219.76 [161.61, 299.31] 195.63 [143.58, 258.05]
 Protein, g 65.13 [47.15, 90.58] 69.10 [49.19, 93.73] 59.82 [44.60, 82.12]
 Total fat, g 63.68 [42.40, 92.38] 67.86 [44.57, 97.17] 57.64 [39.18, 82.85]
 Dietary fiber, g 13.10 [8.50, 19.36] 13.40 [8.60, 20.10] 12.59 [8.30, 18.00]
NHANES cycle  < 0.001
 1999–2000 803 (7.8) 286 (5.1) 517 (13.4)
 2001–2002 887 (8.8) 365 (5.9) 522 (14.8)
 2003–2004 876 (8.6) 342 (6.0) 534 (13.8)
 2005–2006 848 (8.9) 435 (7.4) 413 (12.0)
 2007–2008 1006 (8.8) 566 (8.1) 440 (10.1)
 2009–2010 926 (8.0) 597 (8.2) 329 (7.7)
 2011–2012 1774 (18.7) 1234 (19.8) 540 (16.4)
 2013–2014 938 (10.5) 730 (12.4) 208 (6.5)
 2015–2016 881 (9.7) 752 (12.7) 129 (3.7)
 2017–2018 952 (10.2) 886 (14.4) 66 (1.6)
Drug usage
 Uric acid lowering agent (5.5) (4.7) (7.0) 0.004
 ACEI (22.5) (19.4) (28.9)  < 0.001
 ARB (11.8) (11.2) (13.0) 0.081
 MRA (1.8) (1.3) (3.0)  < 0.001
 SGLT2 (1.6) (1.7) (1.5) 0.724
 ARNI (0.0) (0.1) (0.0) 0.136

Data were expressed as the n (%) or median [IQR]. Percentages were adjusted for NHANES complex survey design. χ2 test and Mann–Whitney U test were utilized for categorical variables and continuous variables respectively.

CKD chronic kidney disease, eGFR estimated glomerular filtration rate, UACR urinary albumin-creatinine ratio, AGR albumin/Globulin Ratio, NHANES National Health and Nutrition Examination Survey.